AOS vs TNGX · P/E 19, rev $1.00B vs $5.36B cap
Smith AO Corporation (AOS) versus Tango Therapeutics Inc (TNGX) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. TNGX currently screens at market cap $5.36B.
Not investment advice. Open the AOS and TNGX stock pages for the full models.
Not investment advice.